Gerard Platenburg, PhD

Chief Scientific Officer at ProQR Therapeutics

Speaker

Gerard is co-founder and has served as ProQR Chief Scientific Officer since 2022, following his tenure as Chief Innovation Officer from 2014 to 2022, and joined ProQR board as an executive director in May 2024. Gerard has an extensive background in RNA modulation and orphan drug discovery and development and is currently in charge of ProQR R&D. Gerard has more than 25 years of senior managerial experience in growing biotech companies. Prior to joining ProQR, Gerard worked at Isa Pharmaceuticals B.V. as its Chief Executive Officer. Gerard co-founded Prosensa Holding N.V., growing it to become a well-known clinical stage RNA modulation company, and held various positions during his tenure including as its Chief Executive Officer and Chief Development Officer. Gerard also worked at Pharming B.V. Gerard is a passionate and driven pioneer of early-stage technologies. Gerard has a master’s degree in Chemistry and Molecular Biology from Leiden University and pursued PhD work at Leiden University.